“That’s so gay” can have real, negative consequences

From thinkprogress.org:

A new study from the University of Michigan has found that simply overhearing the expression “that’s so gay” used to describe something in a disparaging way can have negative consequences for gay, lesbian, or bisexual students. Practically every college student interviewed for the study had heard “that’s so gay” at least once in the past year, with more than half hearing it with much more frequency. Those who heard it more frequently were more likely to report feelings of isolation, as well as negative health symptoms, such as headaches, poor appetite, or eating problems.

Study author Michael Woodford, assistant professor of social work at U-M, describes the results: “Given the nature of gay-lesbian-bisexual stigma, sexual minority students could already perceive themselves to be excluded on campus and earing “that’s so gay” may elevate such perceptions. “That’s so gay” conveys that there is something wrong with being gay.  And, hearing such messages about one’s self can cause stress, which can manifest in headaches and other health concerns.”

Read the full post on thinkprogress.org.

The U.S. Food and Drug Administration approves a new once-a-day combination pill to treat HIV

From the FDA:

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

Stribild contains two previously approved HIV drugs plus two new drugs, elvitegravir and cobicistat. Elvitegravir is an HIV integrase strand transfer inhibitor, a drug that interferes with one of the enzymes that HIV needs to multiply. Cobicistat, a pharmacokinetic enhancer, inhibits an enzyme that metabolizes certain HIV drugs and is used to prolong the effect of elvitegravir. The combination of emtricitabine and tenofovir disoproxil fumarate, approved in 2004 and marketed as Truvada, blocks the action of another enzyme that HIV needs to replicate in a person’s body. Together, these drugs provide a complete treatment regimen for HIV infection.

“Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” said Edward Cox, M.D., M.P.H., director of the Office of Antimicrobial Products in FDA’s Center for Drug Evaluation and Research. “New combination HIV drugs like Stribild help simplify treatment regimens.”

Read the full FDA press release on the FDA Website.

CDC Creates Sex Survey for Gay and Bi Men

From the The Advocate:

The Centers for Disease Control has launched the largest survey ever conducted by a federal agency for gay and bisexual men in the United States at SexistheQuestion.org. According to HRC, Sex in the Question will also make a monetary donation to the It Gets Better Project for every survey complete.

The survey is aimed at understanding men’s sexual behaviors and health and finding ways to deal with STD and HIV transmission among men who have sex with men.

A quick online survey, Sex Is the Question is also one of the first surveys to provide immediate feedback based on participants answers so you know how you compare to other men who are taking the survey as well.

To take the survey and send money to It Gets Better, click here.